lobbying_activities: 635336

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
635336	f1139721-1479-403b-b78d-f7af8e774ecc	Q2	FIERCE, ISAKOWITZ & BLALOCK	44812	COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET	2008	second_quarter	PHA	Biologics S.623/H.R.1038: Access to Life Saving Medicines Act H.R.5629: Pathway for Biosimilars Act S.1695:, Biologics Price Competition and Innovation Act of 2007 State generic drug substitution laws	HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE	50000		0	0	2008-07-17T16:33:18-04:00